Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
OR | 95%CI | P valuea | OR | 95%CI | P value | |
Clinical findings | ||||||
 Age at surgery, year | 1.025 | 1.011–1.040 | < 0.001 |  |  |  |
 Gender: male | 1.058 | 0.755–1.482 | 0.765 |  |  |  |
 Laterality: left | 0.910 | 0.673–1.230 | 0.571 |  |  |  |
 ECOG performance status: 2–4 | 3.061 | 1.340–6.992 | 0.016 |  |  |  |
 Symptomatic presentation | 1.370 | 0.996–1.884 | 0.083 |  |  |  |
 Hypertension | 1.016 | 0.752–1.373 | 0.917 |  |  |  |
 Diabetes | 1.235 | 0.864–1.765 | 0.298 |  |  |  |
 Smoking history | 1.179 | 0.867–1.605 | 0.341 |  |  |  |
 BMI, kg/m2 | 0.971 | 0.929–1.015 | 0.244 |  |  |  |
 Clinical tumor size, cm | 1.424 | 1.269–1.597 | < 0.001 |  |  |  |
 Hemoglobin, g/L | 0.983 | 0.974–0.991 | < 0.001 |  |  |  |
 NLR | 1.081 | 1.042–1.121 | < 0.001 | 1.096 | 1.050–1.145 | < 0.001 |
Surgical findings | ||||||
 Surgical approach |  |  | 0.257 |  |  |  |
  Open | 1(Reference) |  |  |  |  | |
  Laparoscopic | 3.698 | 0.838–16.318 | 0.084 |  |  |  |
  Robotic | 3.323 | 0.721–15.317 | 0.124 |  |  |  |
 Type of nephrectomy: Radical nephrectomy | 3.156 | 2.252–4.424 | < 0.001 |  |  |  |
Imaging findings | ||||||
 Maximal tumor diameter, cm |  |  | 0.515 |  |  |  |
  ≤4 | 1(Reference) |  |  |  |  | |
  >4-<7 | 0.895 | 0.662–1.210 |  |  |  |  |
 Exophytic/endophytic rate |  |  | 0.529 |  |  |  |
  ≥50% | 1(Reference) |  |  |  |  | |
  <50% | 0.854 | 0.606–1.204 | 0.369 |  |  |  |
 Endophytic | 1.112 | 0.738–1.678 | 0.611 |  |  |  |
 Distance to the collecting system, mm |  |  | < 0.001 |  |  | 0.036 |
  >7 | 1(Reference) |  | 1(Reference) |  | ||
  4–7 | 1.093 | 0.641–1.861 | 0.745 | 0.548 | 0.280–1.072 | 0.079 |
  ≤4 | 2.495 | 1.787–3.483 | < 0.001 | 1.360 | 0.888–2.083 | 0.158 |
 Polar location |  |  | 0.086 |  |  |  |
  Entirely above or below the polar line | 1(Reference) |  |  |  |  | |
  Cross the polar line | 1.206 | 0.823–1.766 | 0.336 |  |  |  |
  >50% crosses the polar line, crosses the axial renal midline or entirely between the polar lines | 1.590 | 1.080–2.343 | 0.019 |  |  |  |
 CT necrosis | 6.094 | 4.382–8.474 | < 0.001 | 6.005 | 4.017–8.977 | < 0.001 |
 Calcification | 1.838 | 1.008–3.351 | 0.077 |  |  |  |
 Tumor margin regularity: irregular | 9.341 | 6.345–13.752 | < 0.001 | 8.037 | 5.098–12.669 | < 0.001 |
 Peritumoral neovascularity | 7.352 | 4.249–12.719 | < 0.001 | 3.064 | 1.598–5.875 | 0.001 |
 Pre-contrast phase | ||||||
  TAV-PCP | 1.030 | 1.008–1.052 | 0.016 |  |  |  |
  HDT-PCP | 1.045 | 1.004–1.087 | 0.056 |  |  |  |
 Corticomedullary phase | ||||||
  TAV-CMP | 0.997 | 0.994-1.000 | 0.083 |  |  |  |
  TEV-CMP | 0.994 | 0.994-1.000 | 0.047 |  |  |  |
  RER-CMP | 0.394 | 0.259-0.600 | < 0.001 |  |  |  |
  HDT-CMP | 1.011 | 1.000-1.022 | 0.072 |  |  |  |
 Nephrographic phase | ||||||
  TAV-NP | 0.991 | 0.986–0.996 | 0.003 |  |  |  |
  TEV-NP | 0.989 | 0.983–0.994 | < 0.001 |  |  |  |
  RER-NP | 0.112 | 0.048–0.261 | < 0.001 | 0.133 | 0.047–0.374 | 0.047 |
  HDT-NP | 1.004 | 0.989–1.020 | 0.084 |  |  |  |
 Excretory phase | ||||||
  TAV-EP | 0.993 | 0.985-1.000 | 0.080 |  |  |  |
  TEV-EP | 0.989 | 0.981–0.996 | 0.010 |  |  |  |
  RER-EP | 0.115 | 0.045–0.298 | < 0.001 |  |  |  |
  HDT-EP | 1.032 | 1.009–1.055 | 0.015 |  |  |  |